Published in Springerplus on July 03, 2013
Fetal microchimerism and maternal health: a review and evolutionary analysis of cooperation and conflict beyond the womb. Bioessays (2015) 0.93
Mammary gland involution as an immunotherapeutic target for postpartum breast cancer. J Mammary Gland Biol Neoplasia (2014) 0.79
Epidemiology of basal-like breast cancer. Breast Cancer Res Treat (2007) 7.08
Prolactin: structure, function, and regulation of secretion. Physiol Rev (2000) 4.95
Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol (2008) 3.73
The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer (1980) 3.34
A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol (2007) 2.80
Variables associated with breastfeeding duration. J Obstet Gynecol Neonatal Nurs (2009) 2.73
Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev (2011) 1.71
The relationship between maternal smoking and breastfeeding duration after adjustment for maternal infant feeding intention. Acta Paediatr (2004) 1.63
Developmental, cellular, and molecular basis of human breast cancer. J Natl Cancer Inst Monogr (2000) 1.53
Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger. Breast Cancer Res Treat (2011) 1.47
Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk. Fam Cancer (2007) 1.43
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2004) 1.34
Maternal perceptions of insufficient milk supply in breastfeeding. J Nurs Scholarsh (2008) 1.33
Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells. Cancer Res (2006) 1.23
Prolactin and breast cancer risk. Cancer Lett (2006) 1.20
Inside the lactating breast: the latest anatomy research. J Midwifery Womens Health (2007) 1.10
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res (2012) 1.10
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J Clin Endocrinol Metab (1997) 1.07
Association between common risk factors and molecular subtypes in breast cancer patients. Breast (2012) 1.06
Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer (2006) 1.06
Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies. Mol Aspects Med (2011) 1.02
Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat (2006) 1.00
Socio-economic determinants, maternal smoking and coffee consumption, and exclusive breastfeeding in 10205 children. Acta Paediatr (2005) 0.99
Long-term inequalities in breast cancer survival--a ten year follow-up study of patients managed within a National Health Care System (Sweden). Acta Oncol (2008) 0.98
Prospective assessment of breastfeeding and breast cancer incidence among 89,887 women. Lancet (1996) 0.96
Population attributable risks for breast cancer in Swedish women by morphological type. Breast Cancer Res Treat (2007) 0.96
Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev (2008) 0.94
The association of reproductive factors and breastfeeding with long term survival from breast cancer. Breast Cancer Res Treat (2011) 0.94
The effect of pre-pregnancy BMI on intention, initiation and duration of breast-feeding. Public Health Nutr (2011) 0.94
Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. Br J Cancer (2011) 0.92
CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients. Br J Cancer (2009) 0.92
Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort. Cancer Causes Control (2012) 0.92
Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS One (2012) 0.92
Associations of body size and reproductive factors with circulating levels of sex hormones and prolactin in premenopausal Japanese women. Cancer Causes Control (2011) 0.91
Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol Cell Endocrinol (1999) 0.89
Over-expression of erbB-2/neu is paralleled by inhibition of mouse-mammary-epithelial-cell differentiation and developmental apoptosis. Int J Cancer (2000) 0.87
Breastfeeding and prognostic markers in breast cancer. Breast (2010) 0.83
Insufficient milk supply and breast cancer risk: a systematic review. PLoS One (2009) 0.78
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature (2011) 3.53
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29
2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet (2011) 2.24
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. Eur J Cancer (2004) 1.88
Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol (2003) 1.79
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Cancer (2003) 1.71
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
A pooled analysis of melanocytic nevus phenotype and the risk of cutaneous melanoma at different latitudes. Int J Cancer (2009) 1.51
Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: implications for breast cancer risk. Fam Cancer (2007) 1.43
[Final reply from Hans Wingstrand and co-authors: Reintroduce confidentiality in IT systems]. Lakartidningen (2015) 1.39
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res Treat (2013) 1.38
Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol (2009) 1.30
A variant in FTO shows association with melanoma risk not due to BMI. Nat Genet (2013) 1.17
Molecular profiling reveals low- and high-grade forms of primary melanoma. Clin Cancer Res (2012) 1.17
Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases. Proc Natl Acad Sci U S A (2011) 1.09
Of cup and bra size: reply to a prospective study of breast size and premenopausal breast cancer incidence. Int J Cancer (2006) 1.06
Association between polymorphisms in RMI1, TOP3A, and BLM and risk of cancer, a case-control study. BMC Cancer (2009) 1.05
99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes. J Nucl Med (2012) 1.03
Ki67 proliferation in core biopsies versus surgical samples - a model for neo-adjuvant breast cancer studies. BMC Cancer (2011) 0.98
Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer (2004) 0.97
Cosmetic outcome and breast morbidity in breast-conserving treatment--results from the Danish DBCG-82TM national randomized trial in breast cancer. Acta Oncol (2002) 0.96
Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns. Melanoma Res (2010) 0.95
A systematic overview of radiation therapy effects in breast cancer. Acta Oncol (2003) 0.95
Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16 alpha-hydroxyestrogen metabolites. Mol Genet Metab (2005) 0.95
Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev (2008) 0.94
Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort. Cancer Causes Control (2012) 0.92
Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma. Cancer Lett (2007) 0.92
Challenges in the endocrine management of breast cancer. Breast (2003) 0.92
Characterization of normal breast tissue heterogeneity using time-resolved near-infrared spectroscopy. Phys Med Biol (2005) 0.91
Clinical profiles predict early nonadherence to adjuvant endocrine treatment in a prospective breast cancer cohort. Cancer Prev Res (Phila) (2012) 0.89
Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg (2008) 0.88
Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study. BMC Cancer (2012) 0.87
Wound infiltration with ropivacaine and fentanyl: effects on postoperative pain and PONV after breast surgery. J Clin Anesth (2003) 0.87
Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status. Cancer Causes Control (2013) 0.87
Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules. BMC Clin Pathol (2013) 0.86
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst (2005) 0.86
Molecular and genetic diversity in the metastatic process of melanoma. J Pathol (2014) 0.86
Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden. Acta Oncol (2010) 0.85
Emergency cesarean sections can be predicted by markers for stress, worry and sleep disturbances in first-time mothers. Acta Obstet Gynecol Scand (2011) 0.85
Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions. Int J Cancer (2014) 0.84
A prospective, population-based study of 40,000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma. Int J Cancer (2011) 0.84
Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial. Breast Cancer Res Treat (2011) 0.84
Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma. Eur J Cancer (2012) 0.83
Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype. Melanoma Res (2010) 0.83
The clinicopathological and gene expression patterns associated with ulceration of primary melanoma. Pigment Cell Melanoma Res (2014) 0.83
Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev (2011) 0.83
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients. Int J Cancer (2014) 0.82
Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification. J Proteome Res (2014) 0.81
Increased incidence of childhood, prostate and breast cancers in relatives of childhood cancer patients. Fam Cancer (2012) 0.81
IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer. Fam Cancer (2011) 0.81
Meeting existential needs in palliative care--who, when, and why? J Palliat Care (2002) 0.80
Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability. Clin Transl Med (2013) 0.80
Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort. Cancer Causes Control (2014) 0.80
No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients. Acta Oncol (2013) 0.80
Adjuvant tamoxifen in breast cancer patients affects the endometrium by time, an effect remaining years after end of treatment and results in an increased frequency of endometrial carcinoma. Anticancer Res (2008) 0.80
Analysis of sentinel node biopsy - a single-institution experience supporting the use of serial sectioning and immunohistochemistry for detection of micrometastases by comparing four different histopathological laboratory protocols. Histopathology (2011) 0.79
Identification of plasma protein profiles associated with risk groups of prostate cancer patients. Proteomics Clin Appl (2014) 0.79
Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms. Breast Cancer Res Treat (2012) 0.79
IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families. Breast Cancer Res Treat (2010) 0.79
Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families. Fam Cancer (2007) 0.78
Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families. Mol Genet Metab (2010) 0.78
Breast cancer and spider telangiectasias at diagnosis and its relation to histopathology and prognosis: a population-based study. Breast Cancer Res Treat (2011) 0.77
Characterization of a Trypanosoma cruzi acetyltransferase: cellular location, activity and structure. Mol Biochem Parasitol (2006) 0.77
Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005. Acta Oncol (2008) 0.77
A new look at drugs targeting malignant melanoma--an application for mass spectrometry imaging. Proteomics (2014) 0.77
Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort. Genes Chromosomes Cancer (2014) 0.77
CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women. Mol Hum Reprod (2007) 0.76
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort. BMC Cancer (2014) 0.76
History of oral contraceptive use in breast cancer patients: impact on prognosis and endocrine treatment response. Breast Cancer Res Treat (2015) 0.76